Serial FDG-PET on patients with head and neck cancer: Implications for radiation therapy

International Journal of Radiation Biology

Volumn 85, Issue 9, 2009, Pages 796-804

  Hentschel, Maria ^a,b   Appold, Steffen ^a,b   Schreiber, Andreas ^c   Abramyuk, Andrij ^b   Abolmaali, Nasreddin ^b   Kotzerke, Joerg ^a,b   Baumann, Michael ^a,b   Zöphel, Klaus ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Adaptive planning; FDG PET; Head and neck cancer; Radiotherapy; Therapy monitoring

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GLUCOROS; IOPROMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; BIOLOGICAL TRANSPORT; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TIME FACTORS; TUMOR BURDEN;

EID: 70249086925     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000903039180     Document Type: Article

References (28)

1. Andrade RS, Heron DE, Degirmenci B, Filho PA, Branstetter BF, Seethala RR, Ferris RL, Avril N. 2006. Post treatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. International Journal of Radiation Oncology, Biology, Physics 65:1315-1322.
2. Blodgett TM, Fukui MB, Snyderman CH, Branstetter BF, McCook BM, Townsend DW, Meltzer CC. 2005. Combined PET-CT in the head and neck: Part 1. Physiologic, altered physiologic, and artifactual FDG uptake. Radiographics 25:897-912.
3. Browman GP, Hodson DI, Mackenzie RJ, Bestic N, Zuraw L. 2001. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head & Neck 23:579-589.
4. Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke KD. 2005. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 prospective randomized trial. Journal of Clinical Oncology 23:1125-1135.
5. Caulk RM. 1958. Head and neck cancer from the standpoint of a clinical radiotherapist. Journal.Iowa State Medical Society 48:493-495.
6. Corvo R. 2007. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiotherapy and Oncology 85:156-170.
7. Daisne JF, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H, Gregoire V. 2004. Tumor volume in pharyngolar-yngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233:93-100.
8. De Wit M, Raabe A, Seegers B, Buchert R, Beck-Bornholdt H-P, Alberti W, Hossfeld DK. 2004. Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose. International Journal of Radiation Biology 80:529-539.
9. Frank SJ, Chao KS, Schwartz DL, Weber RS, Apisarnthanarax S, Macapinlac HA. 2005. Technology insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning. Nature Clinical Practice Oncology 2:526-533.
10. Freudenberg LS, Fischer M, Antoch G, Jentzen W, Gutzeit A, Rosenbaum SJ, Bockisch A, Egelhof T. 2005. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary. Medical Principles and Practice 14:155-160.
11. Fukui MB, Blodgett TM, Snyderman CH, Johnson JJ, Myers EN, Townsend DW, Meltzer CC. 2005. Combined PET-CT in the head and neck: Part 2. Diagnostic uses and pitfalls of oncologic imaging. Radiographics 25:913-930.
12. Geets X, Lee JA, Bol A, Lonneux M, Gregoire V. 2007. A gradient-based method for segmenting FDG-PET images: Methodology and validation. European Journal of Nuclear Medicine and Molecular Imaging 34:1427-1438.
13. Gillham C, Zips D, Pönisch F, Evers C, Enghardt W, Abolmaali N, Zöphel K, Appold S, Holscher T, Steinbach J, Kotzerke J, Herrmann T, Baumann M. 2008. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning? Radiotherapy and Oncology 88:335-341.
14. Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, Chao C, Coche E, Cooper JS, Cosnard G, Eisbruch A, El-Sayed S, Emami B, Grau C, Hamoir M, Lee N, Maingon P, Muller K, Reychler H. 2003. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiotherapy and Oncology 69:227-236.
15. Haberkorn U, Strauss LG, Dimitrakopoulou A, Seiffert E, Oberdorfer F, Ziegler S, Reisser C, Doll J, Helus F, van KG. 1993. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. Journal of Nuclear Medicine 34:12-17.
16. Isles MG, McConkey C, Mehanna HM. 2008. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clinical Otolaryngology 33:210-222.
17. Koukourakis MI, Giatromanolaki A, Danielidis V, Sivridis E. 2008. Hypoxia inducible factor (HIF1a and HIF2a) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy. International Journal of Radiation Biology 84:47-52.
18. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. 1992. Intratumoral distribution of fluorine-18-fluorodeox-yglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. Journal of Nuclear Medicine 33:1972-1980.
19. Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, Casilla C, Fazzari M, Srivastava N, Yeung HW, Humm JL, Guillem J, Downey R, Karpeh M, Cohen AE, Ginsberg R. 1999. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The Visual Response Score and the change in total lesion glycolysis. Clinical Positron Imaging 2:159-171.
20. Madani I, Duthoy W, Derie C, De GW, Boterberg T, Saerens M, Jacobs F, Gregoire V, Lonneux M, Vakaet L, Vanderstraeten B, Bauters W, Bonte K, Thierens H, De NW. 2007. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. International Journal of Radiation Oncology, Biology, Physics 68:126-135.
21. Minn H, Paul R, Ahonen A. 1988. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. Journal of Nuclear Medicine 29:1521-1525.
22. Nemeh SA, Lee NY, Schröder H, Squire O, Zanzonico PB, Erdi YE, Greco C, Magetas G, Pham HS, Larson SM, Ling CC, Humm JL. 2008. Reproducibility of intratumor distribution of (18)F-fluromisonidazole in head and neck cancer. International Journal of Radiation Oncology, Biology, Physics 70:235-242.
23. Ong SC, Schoder H, Lee NY, Patel SG, Carlson D, Fury M, Pfister DG, Shah JP, Larson SM, Kraus DH. 2008. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. Journal of Nuclear Medicine 49:532-540.
24. Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, Anzai Y, Haynor D, Lewellyn B, Mattes D, Meyer J, Phillips M, Leblanc M, Kinahan P, Krohn K, Eary J, Laramore GE. 2005. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. International Journal of Radiation Oncology, Biology, Physics 61:129-136.
25. Soret M, Bacharach SL, Buvat I. 2007. Partial-volume effect in PET tumor imaging. Journal of Nuclear Medicine 48:932-945.
26. Wang D, Schultz CJ, Jursinic PA, Bialkowski M, Zhu XR, Brown WD, Rand SD, Michel MA, Campbell BH, Wong S, Li XA, Wilson JF. 2006. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. International Journal of Radiation Oncology, Biology, Physics 65:143-151.
27. Wong RJ. 2008. Current status of FDG-PET for head and neck cancer. Journal of Surgical Oncology 97:649-652.
28. Zöphel K, Appold S, Abolmaali N. 2008. PET/CT-basierte Bestrahlungsplanung bei Patienten mit Kopf-Hals-Tumoren. Der Nuklearmediziner 31:55-59.